Vanta Bioscience Ltd Half Yearly Results

Gross Sales

0.93

1.03

3.55

6.18

3.45

Excise Duty

0

0

0

0

0

Net Sales

0.93

1.03

3.55

6.18

3.45

Other Operating Income

0

0

0

0

0

Other Income

0.07

0.04

0.08

0.03

0.68

Total Income

1

1.07

3.62

6.21

4.13

Total Expenditure

4.81

1.41

4.3

4.11

5.3

PBIDT

-3.8

-0.34

-0.68

2.09

-1.17

Interest

1.92

2.14

2.9

2.85

3.4

PBDT

-5.73

-2.49

-3.57

-0.76

-4.57

Depreciation

2.73

1.69

2.95

1.54

1.36

Minority Interest Before NP

-6.45

-2.06

-4.55

-1.74

-2.1

Tax

0

0

-0.04

0.04

0

Deferred Tax

0.71

-0.05

-0.16

-0.06

0.09

Reported Profit After Tax

-2.71

-2.07

-1.78

-0.54

-3.92

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-2.71

-2.07

-1.78

-0.54

-3.92

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-2.71

-2.07

-1.78

-0.54

-3.92

EPS (Unit Curr.)

-4.29

-3.28

-2.82

-0.85

-6.21

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

6.31

6.31

6.31

6.31

6.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-408.6

-33

-19.15

33.81

-33.91

PBDTM(%)

-

-

-

-

-

PATM(%)

-291.39

-200.97

-50.14

-8.73

-113.62